Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 170, Issue 1, 2013, Pages 100-105

  Govender, Nalini ^a   Naicker, Thajasvarie ^a   Rajakumar, Augustine ^b   Moodley, Jagidesa ^c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

HIV; Preeclampsia; sEng; sFlt1

Indexed keywords

ENDOGLIN; MESSENGER RNA; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL SERUM; PLACENTA; PLACENTA WEIGHT; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; UPREGULATION;

HIV; HIV NEGATIVE NORMOTENSIVE; HIV NEGATIVE PREECLAMPTIC; HIV POSITIVE NORMOTENSIVE; HIV POSITIVE PREECLAMPTIC; HUMAN IMMUNODEFICIENCY VIRUS; N+; N-; P+; P-; PLACENTAL GROWTH FACTOR; PLGF; PREECLAMPSIA; SENG; SFLT1; SOLUBLE ENDOGLIN; SOLUBLE FMS-LIKE TYROSINE KINASE RECEPTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84883054302     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2013.05.021     Document Type: Article

References (36)

1. J.A. Keelan, and M.D. Mitchell Placental cytokines and preeclampsia Front Biosci 12 2007 2706 2727
2. J.A. Keelan, and M.D. Mitchell Cytokines, hypoxia, and preeclampsia J Soc Gynecol Invest 12 2005 385
3. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
4. J.M. Roberts, and H.S. Gammill Preeclampsia: recent insights Hypertension 46 2005 1243 1249
5. J.M. Roberts, and H. Gammill Pre-eclampsia and cardiovascular disease in later life Lancet 366 2005 961 962
6. S.E. Maynard, S. Venkatesha, R. Thandhani, and S.A. Karumanchi Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia Pediatr Res 57 2005 1R 7R
7. V. Tsatsaris, F. Goffin, and C. Munaut Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences J Clin Endocrinol Metab 88 2003 5555 5563
8. S.E. Maynard, J.Y. Min, and J. Merchan Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
9. R.C. Wimalasundera, N. Larbalestier, and J.H. Smith Pre-eclampsia, antiretro viral therapy, and immune reconstitution Lancet 360 2002 1152 1154
10. C. Fourie, J. Van Rooyen, M. Pieters, K. Conradie, T. Hoekstra, and A. Schutte Is HIV-1 infection associated with endothelial dysfunction in a population of african ancestry in South Africa Cardiovasc J Afr 22 2011 134 140
11. A. Suy, E. Martinez, and O. Coll Increased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapy AIDS 20 2006 59 66
12. R. Mattar, A.M. Amed, P.C. Lindsey, N. Sass, and S. Daher Preeclampsia and HIV infection Eur J Obstet Gynecol Reprod Biol 117 2004 240 241
13. D.R. Hall Is preeclampsia less common in patients with HIV/AIDS J Reprod Immunol 76 2007 75 77
14. A. Mawsen Effects of antiretroviral therapy on the occurrence of preeclampsia Lancet 361 2003 347 348
15. K.A. Frank, E.J. Buchmann, and R.C. Schackis Does human immunodeficiency virus infection protect against preeclampsia-eclampsia Obstet Gynecol 104 2004 238 242
16. Y. Bdolah, C. Lam, and A. Rajakumar Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia? Am J Obstet Gynecol 198 2008 428.e1-.e6
17. S. Rana, M.D. Lindheimer, and S.A. Karumanchi Angiogenic proteins as markers for predicting preeclampsia Expert Rev Obstet Gynecol 2 2007 61 65
18. R.J. Levine, C. Lam, and C. Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
19. S. Maynard, F.H. Epstein, and S.A. Karumanchi Preeclampsia and angiogenic imbalance Annu Rev Med 59 2008 61 78
20. I.A. Brosens, W.B. Robertson, and H.G. Dixon The role of spiral arteries in the pathogenesis of preeclampsia Obstet Gynaecol Annu 1 1972 177 191
21. J.M. Roberts, and C.W. Redman Preeclampsia: more than pregnancy induced hypertension Lancet 341 1993 1447 1451
22. S. Venkatesha, M. Toporsian, and C. Lam Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
23. R.J. Levine, C. Lam, and M.S. Cong Qian Soluble endoglin and other circulating antiangiogenic factors in preeclampsia N Engl J Med 355 2006 992 1005
24. M. Hladunewich, S.A. Karumanchi, and R. Lafayette Pathophysiology of the clinical manifestations of preeclampsia Clin J Am Soc Nephrol 2 2007 543 549
25. B. Huppertz Placental origins of preeclampsia: challenging the current hypothesis Hypertension 51 2008 970 975
26. B.D. La Marca, J. Gilbert, and J.P. Granger Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia Hypertension 51 2008 982 988
27. P. Baker, J. Krasnow, J. Roberts, and K. Yeo Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia Obstet Gynecol 86 1995 815 821
28. R.N. Taylor, J. Grimwood, R.S. Taylor, M.T. McMaster, S.J. Fisher, and R.A. North Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies Am J Obstet Gynecol 2003 177 178
29. A.C. Staff, K. Braekke, N.K. Harsem, T. Lyberg, and M.R. Holthe Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia Eur J Obstet Gynecol Reprod Biol 122 2005 33 39
30. Y. Qiu, C. Hoareau-Aveilla, S. Oltean, S.J. Harper, and D.O. Bates The anti-angiogenic isoforms of VEGF in health and disease Biochem Soc Trans 37 2009 1207 1213
31. V.L. Bills, J. Varet, A. Millar, S.J. Harper, P.W. Soothill, and D.O. Bates Failure to up-regulate VEGF165b in maternal plasma is at first trimester predictive marker for preeclampsia Clin Sci 116 2009 265 272
32. S. Rana, S.A. Karumanchi, and R.J. Levine Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia Hypertension 50 2007 137 142
33. R.J. Levine, S.E. Maynard, and C. Qian Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
34. A. Rajakumar, A.S. Cerdeira, and S. Rana Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble Fms-like tyrosine kinase 1 in preeclampsia Hypertension 59 2012 256 264
35. R.J. Levine, and S.A. Karamanchi Circulating angiogenic factors in preeclampsia Clin Obstet Gynecol 48 2005 372 386
36. A. Eskild, and L.J. Vatten Do pregnancies with pre-eclampsia have smaller placentas? A population study of 317 688 pregnancies with and without growth restriction in the offspring Br J Obstet Gynecol 117 2010 1521 1526